Skip to menu Skip to content Skip to footer

2025

Conference Publication

136P Nanopore long-read sequencing reveals epigenomic-genomic interplay in oesophageal adenocarcinoma

Do, J.Y., Aoude, L.G., Gamaarachchi, H., Ferguson, J., Rapadas, M., Hammond, J., Amos, T.G., Waddell, N., Barbour, A.P., Deveson, I. and Naeini, M.M. (2025). 136P Nanopore long-read sequencing reveals epigenomic-genomic interplay in oesophageal adenocarcinoma. Molecular Analysis for Precision Oncology Congress, Paris, France, 15-16 September 2025. Viganello-Lugano, Switzerland: Elsevier. doi: 10.1016/j.esmoop.2025.105714

136P Nanopore long-read sequencing reveals epigenomic-genomic interplay in oesophageal adenocarcinoma

2025

Conference Publication

Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens

Lonie, James, Brosda, Sandra, Addala, Venkateswar, Bonazzi, Vanessa, Aoude, Lauren, Zeng, Bijun, Waddell, Nicola, Dolcetti, Riccardo and Barbour, Andrew (2025). Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.314

Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma by harnessing tumour neoantigens

2025

Conference Publication

Identifying genetic drivers of oesophageal adenocarcinoma

Aoude, Lauren G., Brosda, Sandra, Wong, Ho Yi, Koufariotis, Lambros, Pearson, John V., Waddell, Nicola and Barbour, Andrew P. (2025). Identifying genetic drivers of oesophageal adenocarcinoma. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.354

Identifying genetic drivers of oesophageal adenocarcinoma

2025

Conference Publication

Spatial transcriptomics profiling of the tumour microenvironment of esophageal adenocarcinoma

Belle, Clemence, Brosda, Sandra, Bonazzi, Vanessa, Kao, Yung-Ching, Brown, Ian, Aoude, Lauren, Stark, Mitchell, Patel, Kalpana, AGITG AGITG DOCTOR Investigators, Atkinson, Victoria and Barbour, Andrew (2025). Spatial transcriptomics profiling of the tumour microenvironment of esophageal adenocarcinoma. 21st ISDE World Congress for Esophageal Diseases, Brisbane, QLD Australia, 18-20 September 2025. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/dote/doaf061.357

Spatial transcriptomics profiling of the tumour microenvironment of esophageal adenocarcinoma

2025

Conference Publication

Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomics

Belle, Clemence J., Brosda, Sandra, Bonazzi, Vanessa F., Bulteau, Victor, Stuart, Thomas, Xiong, Zherui, Lambie, Duncan, Johansson, Peter A., Aoude, Lauren G., Patel, Kalpana, Stehbens, Samantha J., Stark, Mitchell S., Haass, Nikolas K., Xu, Wen, Pinkham, Mark B., Foote, Matthew C., Olson, Sarah, Atkinson, Victoria, Kulasinghe, Arutha, Nguyen, Quan H. and Barbour, Andrew (2025). Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomics. AACR Annual Meeting 2025, Chicago, IL United States, 25-30 April 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2025-5076

Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomics

2024

Conference Publication

Unsupervised clustering of PET/CT imaging features in stage III/IV melanoma

Vashistha, Rajat, Moradi, Hamed, Brosda, Sandra, Aoude, Lauren, Vegh, Viktor and Barbour, Andrew (2024). Unsupervised clustering of PET/CT imaging features in stage III/IV melanoma. Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Toronto, ON, Canada, 8-11 June 2024. Reston, VA, United States: Society of Nuclear Medicine.

Unsupervised clustering of PET/CT imaging features in stage III/IV melanoma

2023

Conference Publication

Unusual suspects in hereditary melanoma: POT1, POLE and BAP1

Maas, Ellie, Betz-Stablein, Brigid, Aoude, Lauren, Soyer, Hans Peter and McInerney-Leo, Aideen (2023). Unusual suspects in hereditary melanoma: POT1, POLE and BAP1. 55th European Society of Human Genetics (ESHG) Conference, Vienna, Austria, 11-14 June 2022. London, United Kingdom: Nature Publishing Group.

Unusual suspects in hereditary melanoma: POT1, POLE and BAP1

2022

Conference Publication

Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma

Aoude, L.G., Bonazzi, V.F., Brosda, S., Wong, B., Moradi, H., Lonie, J., Bradford, J., Bloxham, C., Atkinson, V.G., Law, P., Lampe, G., Smithers, M., Waddell, N., Vegh, V., Miles, K. and Barbour, A.P. (2022). Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma. ESMO Congress 2022, Singapore, 9 - 13 September 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2022.07.1357

Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma

2022

Conference Publication

Classification of esophageal adenocarcinoma into subgroups that are associated with patient survival using RNA-seq and immunohistochemistry

Sharma, Sowmya, Naeini, Marjan, Aoude, Lauren G., Bonazzi, Vanessa F., Gartside, Michael G., Loffler, Kelly A., Patel, Kalpana, Newell, Felicity, Lampe, Guy, Brosda, Sandra, Thomas, Janine, Smithers, Mark, Simes, John, Watson, David I., Pearson, John, Barbour, Andrew and Waddell, Nic (2022). Classification of esophageal adenocarcinoma into subgroups that are associated with patient survival using RNA-seq and immunohistochemistry. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Classification of esophageal adenocarcinoma into subgroups that are associated with patient survival using RNA-seq and immunohistochemistry

2020

Conference Publication

Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome

Naeini, Marjan, Newell, Felicity, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Koufariotis, Lambros T., Johnson, Rebecca, Addala, Venkateswar, Kondrashova, Olga, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Xu, Christina, Nones, Katia, Pearson, John V., Smithers, Mark, Watson, David, Simes, John, Price, Tim, Gebski, Val, Barbour, Andrew P. and Waddell, Nic (2020). Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome. HOBOKEN: WILEY.

Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome

2017

Conference Publication

Novel high risk genes of melanoma

Hayward, N., Pritchard, A., Johansson, P., Aoude, L., Jonsson, G., Hoiom, V., Wadt, K. and Adams, D. (2017). Novel high risk genes of melanoma. 13th Congress of the European Association of Dermato‐Oncology (EADO), Athens, Greece, 3–6 May 2017. Hoboken, NJ United States: Wiley.

Novel high risk genes of melanoma

2017

Conference Publication

Novel germline variants in cutaneous and uveal melanoma families

Hayward, N., Pritchard, A., Johansson, P., Aoude, L., Jonsson, G., Hoiom, V. and Wadt, K. (2017). Novel germline variants in cutaneous and uveal melanoma families. 13th Congress of the European Association of Dermato‐Oncology (EADO), Athens, Greece, 3–6 May 2017. Hoboken, NJ United States: Wiley.

Novel germline variants in cutaneous and uveal melanoma families

2008

Conference Publication

Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer

Aoude, L., Ferguson, B., Gordon, V., Johns, J., Maslovskaya, L., Parsons, P., Pierce, C., Reddell, P., Savchenko, A. and Williams, C. (2008). Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer. 4th Australian Health and Medical Research Congress, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer